Bleeding risk with anticoagulant and
antiplatelet medications is something that we struggle with on a regular
basis. Should we fully anticoagulate a
patient with atrial fibrillation who is falling? Should we continue the aspirin and
clopidogrel even though it’s X number of months since their stents?
Sunday, November 10, 2013
Sunday, November 3, 2013
New drug of abuse comes to America – Enter krokodil
Reports developed in
the media last month identifying suspected cases of ‘krokodil’ use in Utah, Arizona,
and Illinois. While the drug’s presence
has not officially been confirmed there is a significant health concern when
considering this new drug’s properties and what the results of its use are.
Recommended for you
-
The 2016 American Diabetes Association diabetes guidelines is a lengthy document outlining many aspects of diabetes care including eval... -
Let’s start with a patient case. A patient is being treated with methylprednisolone 20 mg IV q6 hours for some inflammatory process and... -
A 48 year old male is admitted to the hospital after experiencing a fever and malaise for several days. He states that he has some shortn... -
A 55 year old business executive is being discharged from the hospital after a brief admission for cellulitis. His only PMH is HTN and o... -
Daptomycin (Cubicin) is the first antibiotic in a class known as lipopeptides and has a unique mechanism of action. Daptomycin is a large... -
Since July is here and the academic calendar is starting over, it is time for new medical residents to be arriving to the hospital floors... -
.PNG)
Homeopathy is a part of complementary and alternative medicine (CAM) that is an undeniable component of the healthcare industry in the U... -
The American Geriatrics Society recently published their Alternative Treatments to Selected Medications in reference to the most recent upd... -
A 60 year old female patient presents to the emergency department with complaints of swelling and pain in her right leg. She recently had... -
Midodrine is a peripherally-acting selective alpha1 receptor agonist . Let's take that sentence apart to see what we should expect ...